Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the ...

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...

We nominate Jessica MacIntyre for the 2025 Extraordinary Healer Award for Oncology Nursing for her personal, local and ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

Discrepancies between patients' experiences and friends' lives can strain relationships, highlighting the need for ...